Publication | Closed Access

Droloxifene, a new anti-oestrogen in postmenopausal advanced breast cancer: Preliminary results of a double-blind dose-finding phase II trial

Breast OncologyOncologyMedicineNew Anti-oestrogenPreliminary ResultsBreast CancerPharmacotherapyAnti-cancer AgentPharmacologyRadiation OncologyMenopause Hormone Therapy